Skip to main content

Halozyme Therapeutics, Inc 10-K for FY2024

Halozyme Therapeutics, Inc. (HALO)

10-K 2025-02-18 For: 2024-12-31
View Original
Added on April 11, 2026

About this 10-K

Halozyme Therapeutics, Inc filed this 10-K on February 18, 2025, covering the fiscal year ended December 31, 2024 (FY2024).

Headline figures

Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$1.02B
up 22.4% from $829.25M a year earlier
Net income
$444.09M
up 57.7% from net income of $281.59M a year earlier
Diluted EPS
$3.43
up 63.3% from $2.10 a year earlier